Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorHenan University of Traditional Chinese Medicine
About this trial
The purpose of this study was to evaluate the effects of Chinese Medicine on patients with severe AECOPD, and to provide a basis for the establishment of integrated CM and Western medicine diagnosis and treatment scheme for patients with severe AECOPD.
Eligibility criteria
Qualifiers
Patients with severe AECOPD.;
Age 40-80 years old;
Chinese medicine diagnosis consistent with external cold and internal drink syndrome, or phlegm-heat congestion of the lungs syndrome, or phlegm turbidity obstruction of the lungs syndrome;
Voluntarily accept the treatment and sign the informed consent form;
Disqualifiers
Pregnant and lactating women.
delirious, dementia, various mental patients and other people who cannot communicate normally.
Patients with severe cardiac insufficiency (NYHA grade IV), malignant arrhythmia and hemodynamic instability.
Patients with acute respiratory failure who require tracheal intubation or invasive mechanical ventilation.
Trial design
Treatments tested in this trial
- Sanhan Huayin recipe, Qingre Huatan recipe or Zaoshi Huatan recipe
- Sanhan Huayin recipe placebo, Qingre Huatan recipe placebo or Zaoshi Huatan recipe placebo
Treatment groups
468 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Henan University of Traditional Chinese Medicine
Lead sponsor
Peking University Third Hospital
Collaborator
Jiangsu Province Hospital of Traditional Chinese Medicine
Collaborator
Chengdu University of Traditional Chinese Medicine
Collaborator
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Collaborator
Shenzhen Hospital of Southern Medical University
Collaborator
Qingdao Haici Hospital
Collaborator
Xiangyang Hospital of Traditional Chinese Medicine
Collaborator
Source ClinicalTrials.gov